Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Total Debt (2023 - 2025)

Onconetix (ONCO) has disclosed Total Debt for 2 consecutive years, with $243081.0 as the latest value for Q3 2024.

  • On a quarterly basis, Total Debt rose 2223.69% to $243081.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $243081.0, a 2223.69% increase, with the full-year FY2023 number at $121498.0, changed N/A from a year prior.
  • Total Debt was $243081.0 for Q3 2024 at Onconetix, up from $113901.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $476598.0 in Q2 2023 to a low of $10461.0 in Q3 2023.